Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.
about
Developmental therapeutics for inflammatory breast cancer: Biology and translational directionsClonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- VinorelbineChallenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerPrecision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials.Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?PIK3CA mutations in HER2-positive Breast Cancer Patients; Frequency and Clinicopathological Perspective in Egyptian PatientsIdentification of frequent somatic mutations in inflammatory breast cancer.Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer.Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients.Clinical validation of the Tempus xO assay.Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
P2860
Q28075322-95B4EED6-AC4C-43FA-A25F-4E1DEF7F4AE5Q28554790-3A068120-C9FB-4A2D-AFCF-CD9A02FDE921Q33760216-FAECFC41-21E3-44D6-9951-D09EA22ACCB1Q36214202-A5D57912-8FF4-4BA5-B166-70C239B241BBQ38656155-02FA05B3-EBBF-4804-8DAF-40A617BBBF42Q38683638-210604EA-DD5D-4FDE-84C6-7D0530ED00D3Q38752902-CC5210E3-3F92-4107-A8F8-403B80C50190Q38938061-3E610179-57D6-446E-AD6A-280410B66F1AQ39442392-C37C6B81-70ED-4DCF-882E-9BBE84DD98A6Q45916506-2DA0FF98-90CA-46EA-B9DC-6DBB87B724B1Q51711213-633BE327-44BC-4FBF-B821-F52E5C9E9902Q55091748-2CF1174A-ED30-46CC-91FD-9709D93848E5Q58797604-7B119C98-E2B7-4D5A-B6A8-A69ABF1CCFFE
P2860
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Comprehensive genomic profilin ...... relevant genomic alterations.
@en
type
label
Comprehensive genomic profilin ...... relevant genomic alterations.
@en
prefLabel
Comprehensive genomic profilin ...... relevant genomic alterations.
@en
P2093
P2860
P1476
Comprehensive genomic profilin ...... relevant genomic alterations.
@en
P2093
Deborah Morosini
Depinder Khaira
Gary A Palmer
Jeffrey S Ross
Julia A Elvin
Massimo Cristofanilli
Norma A Palma
Philip J Stephens
Sandra V Fernandez
P2860
P2888
P304
P356
10.1007/S10549-015-3592-Z
P407
P577
2015-10-12T00:00:00Z
P5875
P6179
1011942184